Andeea Robe
Floreşti, Cluj, 407280, Romania
Location status: Recruiting
NCT Number: NCT06534515
The current study aims to explore the preliminary efficacy of the Tomatis method on auditory processing in children with NDDs.
Interested in participating?
Request Info4 year–17 year
All sexes
Interventional
Not applicable
Floreşti, Cluj, 407280, Romania
Location status: Recruiting
This will be a two-arm, randomized controlled trial exploring whether the Tomatis training could improve the components of auditory processing in children with Neurodevelopmental Disorders referred to a Romanian Child and Adolescent Psychiatric Unit. Outcomes assessment will be conducted at baseline (T1), immediately after the training (T2).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Traditional Tomatis Method Protocol
Time frame: Change from baseline AC (time 0) at immediately after the intervention (time 1)
% Spatialization errors in air conduction
Time frame: Change from baseline BC(time 0) at immediately after the intervention (time 1)
% Spatialization errors in Bone conduction
Time frame: Change from baseline DD_CGAS (time 0) at immediately after the intervention (time 1)
Developmental Disability Children's Global Assesment Scale total score(highest score 100; superior functioning; lowest score 1: extreme impairment)
Contact information is provided by the study sponsor or research team.
Babes-Bolyai University
Other
The Effect of Tomatis Auditory Stimulation in Children and Adolescent With Neurodevelopmental Disorders (TomatisOn)
Acronym: TomatisOn
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06081348
22Q11 Deletion, 22q11 Deletion Syndrome
Calgary, Alberta, Canada
View Trial DetailsNCT04096430
Autism Spectrum Disorder, Brain Damage, Chronic
Calgary, Alberta, Canada
View Trial DetailsNCT06776341
GEMIN5 Protein, Human, Mental Disorders
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05432349
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Disease
Birmingham, Alabama, United States
View Trial Details